In conversation with experts, we’ll break down what you need to know about the most commonly prescribed type of contraception in the United States: the pill. “The most common and most familiar ...

The best pill organizers help me stay on track and make travel a breeze, ensuring everything is secure and in its place. Like its contents, pill cases come in all different shapes and sizes ...

Here’s our process. Several effective pills for erectile dysfunction (ED) are available. Learn which pills may be most effective for you based on dosage, onset, duration, and interactions with ...

The pill is made by Novo Nordisk, the same company that makes Ozempic. The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

Follow along. Hims Hard Mints are a discreet alternative to erectile dysfunction pills. They’re created by a process called compounding. Compounded medications are customized or altered to meet ...

There is a new chapter in Big Pharma’s billion-dollar war on obesity, as Novo Nordisk and Eli Lilly battle it out over the latest blockbuster drugs. Ozempic maker Novo Nordisk’s highly ...

Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone led to substantial weight loss in an early study, boosting the company’s pipeline of next-generation ...

Ozempic maker Novo Nordisk says its highly anticipated experimental weight-loss pill Amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects.

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a Phase 3 study, potentially clearing the way for regulatory approval, although in two other studies ...

The maker of blockbuster drugs Wegovy and Ozempic said in March that a Phase I trial of the pill version of amycretin showed participants lost up to 13.1% of their weight after 12 weeks ...